Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works

A novel coronavirus from patients with pneumonia in China, 2019

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244 · see citing works

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · see citing works

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · see citing works

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545 · see citing works

Endothelial cell infection and endotheliitis in COVID-19

Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358 · see citing works

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

Bernard, G. R., Vincent, J., Laterre, P., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,124 · see citing works

Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signaling

Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,759 · see citing works

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · see citing works

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015432 · Cited by 5,613 · see citing works

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Tang, N., Bai, H., Chen, X., Gong, J., Li, D., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14817 · Cited by 3,554 · see citing works

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Helms, J., Tacquard, C. A., Séverac, F., Léonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clère-Jehl, R., Schenck, M., Gandet, F. F., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,818 · see citing works

COVID-19 and its implications for thrombosis and anticoagulation

Connors, J. M., & Levy, J. H. (2020) · Blood · doi:10.1182/blood.2020006000 · Cited by 2,377 · see citing works

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Wichmann, D., Sperhake, J., Lütgehetmann, M., Steurer, S. A., Edler, C., Heinemann, A., Heinrich, F., Mushumba, H., Kniep, I., Schröder, A. S., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2003 · Cited by 2,271 · see citing works

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases

MAGRO, C. M. J., Mulvey, J. J., Berlin, D., Nuovo, G. J., Salvatore, S., HARP, J. L., Baxter-Stoltzfus, A., & Laurence, J. C. (2020) · Translational research · doi:10.1016/j.trsl.2020.04.007 · Cited by 2,185 · see citing works

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179 · see citing works

Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19

Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr2005760 · Cited by 2,101 · see citing works

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

Lodigiani, C., Iapichino, G., Carenzo, L., Cecconi, M., Ferrazzi, P., Sebastian, T., Kucher, N., Studt, J.-D., Sacco, C., Bertuzzi, A., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.024 · Cited by 2,054 · see citing works

Evolving functions of endothelial cells in inflammation

Pober, J. S., & Sessa, W. C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2171 · Cited by 2,022 · see citing works

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19

Thachil, J. V., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M. M., Clark, C., & Iba, T. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14810 · Cited by 1,957 · see citing works

Cytokine release syndrome in severe COVID-19

Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912 · see citing works

Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China

Su, H., Yang, M., Wan, C., Yi, L.-X., Tang, F., Zhu, H.-Y., Yi, F., Yang, H.-C., Fogo, A. B., Nie, X., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.04.003 · Cited by 1,763 · see citing works

The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease

McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102537 · Cited by 1,654 · see citing works

Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis

Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.041 · Cited by 1,601 · see citing works

The Vascular Endothelium and Human Diseases

Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthisekaran, D., Sethi, G., & Nishigaki, I. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.7502 · Cited by 1,473 · see citing works

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., & Stebbing, J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30304-4 · Cited by 1,456 · see citing works

Incidence of venous thromboembolism in hospitalized patients with COVID‐19

Middeldorp, S., Coppens, M., van Haaps, T. F., Foppen, M., Vlaar, A. P. J., Müller, M. C. A., Bouman, C. S. C., Beenen, L. F. M., Kootte, R. S., Heijmans, J., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14888 · Cited by 1,453 · see citing works

Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer

Tian, S., Hu, W., Niu, L., Liu, H., Xu, H., & Xiao, S. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.02.010 · Cited by 1,414 · see citing works

COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome

Gattinoni, L., Coppola, S., Cressoni, M., Busana, M., Rossi, S., & Chiumello, D. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0817le · Cited by 1,396 · see citing works

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z., Wang, J., Qin, Y., Zhang, X., Yan, X., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108393 · Cited by 1,266 · see citing works

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.04.037 · Cited by 1,237 · see citing works

Classification of the cutaneous manifestations of COVID ‐19: a rapid prospective nationwide consensus study in Spain with 375 cases

Galván‐Casas, C., Català, A., Hernández, G. C., Rodríguez‐Jiménez, P., Fernández‐Nieto, D., Lario, A. R., Fernández, I. N., Ruíz‐Villaverde, R., Falkenhain‐López, D., Velasco, M. L., et al. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19163 · Cited by 1,230 · see citing works

Prominent changes in blood coagulation of patients with SARS-CoV-2 infection

Han, H. W., Yang, L., Liu, R., Liu, F., Wu, K.-L., Li, J., Liu, X., & Zhu, C.-L. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0188 · Cited by 1,226 · see citing works

Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction

Menter, T., Haslbauer, J. D., Nienhold, R., Savic, S., Hopfer, H., Deigendesch, N., Frank, S., Turek, D., Willi, N., Pargger, H., et al. (2020) · Histopathology · doi:10.1111/his.14134 · Cited by 1,207 · see citing works

High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients

Llitjos, J., Leclerc, M., Chochois, C., Monsallier, J.-M., Ramakers, M., Auvray, M., & Merouani, K. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14869 · Cited by 1,199 · see citing works

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Gianfrancesco, M. A., Hyrich, K. L., Al-Adely, S., Carmona, L., Danila, M. I., Gossec, L., Izadi, Z., Jacobsohn, L., Katz, P., Lawson‐Tovey, S., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217871 · Cited by 1,142 · see citing works

The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients

Yang, A.-P., Liu, J.-P., Tao, W.-Q., & Li, H.-M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106504 · Cited by 1,138 · see citing works

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

Watson, T., Shantsila, E., & Lip, G. Y. H. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60040-4 · Cited by 1,124 · see citing works

COVID-19: the vasculature unleashed

Teuwen, L.-A. M. N., Geldhof, V., Pasut, A., & Carmeliet, P. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0343-0 · Cited by 1,010 · see citing works

The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome

Ranucci, M., Ballotta, A., Dedda, U. D., Baryshnikova, E., Poli, M., Resta, M. V., Falco, M., Albano, G., & Menicanti, L. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14854 · Cited by 962 · see citing works

Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies

Tian, S., Xiong, Y., Liu, H., Niu, L., Guo, J., Liao, M., & Xiao, S. (2020) · Modern Pathology · doi:10.1038/s41379-020-0536-x · Cited by 938 · see citing works

COVID-19 Autopsies, Oklahoma, USA

Barton, L. M., Duval, E. J., Stroberg, E., Ghosh, S., & Mukhopadhyay, S. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa062 · Cited by 832 · see citing works

Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia

McGonagle, D., O’Donnell, J. S., Sharif, Κ., Emery, P., & Bridgewood, C. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30121-1 · Cited by 826 · see citing works

Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors

Gasparyan, A. Y., Ayvazyan, L., Blackmore, H. L., & Kitas, G. D. (2011) · Rheumatology International · doi:10.1007/s00296-011-1999-3 · Cited by 801 · see citing works

Deployment of convalescent plasma for the prevention and treatment of COVID-19

Bloch, E. M., Shoham, S., Casadevall, A., Sachais, B. S., Shaz, B. H., Winters, J. L., van Buskirk, C. M., Grossman, B. J., Joyner, M. J., Henderson, J. P., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138745 · Cited by 798 · see citing works

Findings of lung ultrasonography of novel corona virus pneumonia during the 2019–2020 epidemic

Chinese Critical Care Ultrasound Study Group (CCUSG), Peng, Q., Wang, X., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05996-6 · Cited by 741 · see citing works

SARS-CoV-2 and Stroke in a New York Healthcare System

Yaghi, S. R., Ishida, K., Torres, J., Grory, B. M., Raz, E., Humbert, K. A., Henninger, N., Trivedi, T., Lillemoe, K., Alam, S., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.030335 · Cited by 737 · see citing works

Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome

Lax, S., Skok, K., Zechner, P. M., Kessler, H. H., Kaufmann, N., Koelblinger, C., Vander, K., Bargfrieder, U., & Trauner, M. A. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2566 · Cited by 730 · see citing works

Characteristics of ischaemic stroke associated with COVID-19

Beyrouti, R., Adams, M. E., Benjamin, L., Cohen, H., Farmer, S. F., Goh, Y. Y., Humphries, F., Jäger, H. R., Losseff, N. A., Perry, R. J., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323586 · Cited by 711 · see citing works

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

Ramiro, S., Gaujoux-Viala, C., Nam, J. L., Smolen, J. S., Buch, M. H., Gossec, L., van der Heijde, D. M. F. M., Winthrop, K. L., & Landewé, R. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204575 · Cited by 701 · see citing works

COVID-19 update: Covid-19-associated coagulopathy

Becker, R. C. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02134-3 · Cited by 698 · see citing works

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Wichmann, D. (2020) · Annals of Internal Medicine · doi:10.7326/l20-1206 · Cited by 630 · see citing works

The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases

Gasparyan, A. Y., Ayvazyan, L., Mukanova, U., Yessirkepov, M., & Kitas, G. D. (2019) · Annals of Laboratory Medicine · doi:10.3343/alm.2019.39.4.345 · Cited by 607 · see citing works

Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d -Dimer Levels

Léonard-Lorant, I., Delabranche, X., Séverac, F., Helms, J., Pauzet, C., Collange, O., Schneider, F., Labani, A., Bilbault, P., Molière, S., et al. (2020) · Radiology · doi:10.1148/radiol.2020201561 · Cited by 591 · see citing works

Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19

Qu, R., Ling, Y., Zhang, Y., Wei, L., Chen, X., Li, X., Liu, X., Liu, H., Guo, Z., Ren, H., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25767 · Cited by 583 · see citing works

COVID-19 presenting as stroke

Avula, A., Nalleballe, K., Narula, N., Sapozhnikov, S., Dandu, V., Toom, S., Glaser, A., & Elsayegh, D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.077 · Cited by 558 · see citing works

Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected with Pulmonary CT Angiography

Grillet, F., Behr, J., Calame, P., Aubry, S., & Delabrousse, É. (2020) · Radiology · doi:10.1148/radiol.2020201544 · Cited by 552 · see citing works

Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series

Wang, J., Hajizadeh, N., Moore, E. E., McIntyre, R. C., Moore, P. K., Veress, L. A., Yaffe, M. B., Moore, H. B., & Barrett, C. D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14828 · Cited by 536 · see citing works

Hypoxic Pulmonary Vasoconstriction

Dunham‐Snary, K. J., Wu, D., Sykes, E. A., Thakrar, A., Parlow, L. R. G., Mewburn, J. D., Parlow, J. L., & Archer, S. L. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.09.001 · Cited by 515 · see citing works

Complement as a target in COVID-19?

Risitano, A. M., Mastellos, D. C., Huber-Lang, M. S., Yancopoulou, D., Garlanda, C., Ciceri, F., & Lambris, J. D. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0320-7 · Cited by 480 · see citing works

Use of Glucocorticoids and Risk of Venous Thromboembolism

Schmidt, S. A. J., Horváth–Puhó, E., Dekkers, O. M., Cannegieter, S. C., Jørgensen, J. O. L., Ehrenstein, V., Vandenbroucke, J. P., Pedersen, L. H., & Sørensen, H. T. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.122 · Cited by 467 · see citing works

Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting

Smeeth, L. L., Cook, C., Thomas, S., Hall, A. J., Hubbard, R., & Vallance, P. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68474-2 · Cited by 454 · see citing works

Severe COVID-19 infection associated with endothelial activation

Escher, R., Breakey, N., & Lämmle, B. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.014 · Cited by 440 · see citing works

Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions

Raggi, P., Genest, J. J., Giles, J. T., Rayner, K. J., Dwivedi, G., Beanlands, R. S., & Gupta, M. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.07.014 · Cited by 434 · see citing works

Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection

Wright, F. L., Vogler, T. O., Moore, E. E., Moore, H. B., Wohlauer, M. V., Urban, S., Nydam, T. L., Moore, P. K., & McIntyre, R. C. (2020) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2020.05.007 · Cited by 417 · see citing works

Pulmonary embolism in patients with COVID-19 pneumonia

Bompard, F., Monnier, H., Saab, I., Tordjman, M., Abdoul, H., Fournier, L. S., Sanchez, O., Lorut, C., Chassagnon, G., & Revel, M. (2020) · European Respiratory Journal · doi:10.1183/13993003.01365-2020 · Cited by 379 · see citing works

Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings

Baergen, R. N., & Heller, D. S. (2020) · Pediatric and Developmental Pathology · doi:10.1177/1093526620925569 · Cited by 361 · see citing works

Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels

Rodríguez, P. D., Cervilla‐Muñoz, E., Ordieres‐Ortega, L., Parra‐Virto, A., Toledano‐Macías, M., Samaniego, N. T., García-García, A., García-Fernández-Bravo, I., Ji, Z., de Miguel‐Díez, J., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.05.018 · Cited by 353 · see citing works

Thrombo-inflammation in acute ischaemic stroke — implications for treatment

Stoll, G., & Nieswandt, B. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0221-1 · Cited by 336 · see citing works

Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration

Sodhi, C. P., Wohlford-Lenane, C., Yamaguchi, Y., Prindle, T., Fulton, W. B., Wang, S., McCray, P. B., Chappell, M. C., Hackam, D. J., & Jia, H. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00498.2016 · Cited by 333 · see citing works

Pulmonary and systemic involvement in COVID‐19 patients assessed with ultrasound‐guided minimally invasive autopsy

Duarte‐Neto, A. N., Monteiro, R. A. D. A., da Silva, L. F. F., Malheiros, D. M. A. C., Oliveira, E. P., Filho, J. T., Pinho, J. R. R., Gomes‐Gouvêa, M. S., Salles, A. P. M., de Oliveira, I. R. S., et al. (2020) · Histopathology · doi:10.1111/his.14160 · Cited by 328 · see citing works

Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience.

Diurno, F., Numis, F. G., Porta, G., et al. (2020) · PubMed · doi:10.26355/eurrev_202004_20875 · Cited by 327 · see citing works

Pathogenesis of the Viral Hemorrhagic Fevers

Paessler, S., & Walker, D. H. (2012) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164041 · Cited by 309 · see citing works

Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis

Karakike, E., & Giamarellos‐Bourboulis, E. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00055 · Cited by 304 · see citing works

Review: Viral infections and mechanisms of thrombosis and bleeding

Goeijenbier, M., Wissen, M. V., van de Weg, C., Jong, E., Gerdes, V. E. A., Meijers, J. C. M., Brandjes, D. P. M., & Gorp, E. C. M. V. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23354 · Cited by 299 · see citing works

Antiphospholipid antibodies and infections

Asherson, R. A., & Cervera, R. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.5.388 · Cited by 282 · see citing works

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis

Sepriano, A. R., Kerschbaumer, A., Smolen, J. S., van der Heijde, D. M. F. M., Dougados, M., van Vollenhoven, R., McInnes, I. B., Bijlsma, J. W. J., Burmester, G. R., de Wit, M. P. T., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216653 · Cited by 277 · see citing works

Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets

Misra, D. P., Agarwal, V., Gasparyan, A. Y., & Zimba, O. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05073-9 · Cited by 272 · see citing works

Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19

Whyte, C. S., Morrow, G. B., Mitchell, J. L., Chowdary, P., & Mutch, N. J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14872 · Cited by 271 · see citing works

Stroke in patients with SARS-CoV-2 infection: case series

Morassi, M., Bagatto, D., Cobelli, M., D’Agostini, S., Gigli, G. L., Bnà, C., & Vogrig, A. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09885-2 · Cited by 269 · see citing works

Will Complement Inhibition Be the New Target in Treating COVID-19–Related Systemic Thrombosis?

Campbell, C. M., & Kahwash, R. (2020) · Circulation · doi:10.1161/circulationaha.120.047419 · Cited by 267 · see citing works

Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation

Iba, T., Levi, M. M., & Levy, J. H. (2019) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0039-1694995 · Cited by 258 · see citing works

Complement activation in patients with COVID-19: A novel therapeutic target

Cugno, M., Meroni, P. L., Gualtierotti, R., Griffini, S., Grovetti, E., Torri, A., Panigada, M., Aliberti, S., Blasi, F., Tedesco, F., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.006 · Cited by 247 · see citing works

New SARS-like virus in China triggers alarm

Cohen, J., & Normile, D. (2020) · Science · doi:10.1126/science.367.6475.234 · Cited by 238 · see citing works

Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review

Alijotas‐Reig, J., Esteve‐Valverde, E., Belizna, C. C., Selva-O’Callaghan, A., Pardos‐Gea, J., Quintana, Á., MEKINIAN, A., Anunciación-Llunell, A., & Miró‐Mur, F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102569 · Cited by 236 · see citing works

Acute Pulmonary Embolism and COVID-19

Poyiadji, N., Cormier, P., Patel, P., Hadied, M., Bhargava, P., Khanna, K., Nadig, J., Keimig, T., Spizarny, D., Reeser, N., et al. (2020) · Radiology · doi:10.1148/radiol.2020201955 · Cited by 228 · see citing works

COVID-19-associated hyperviscosity: A link between inflammation and thrombophilia?

Maier, C. L., Truong, A. D., Auld, S. C., Polly, D. M., Tanksley, C.-L., & Duncan, A. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31209-5 · Cited by 226 · see citing works

SARS-CoV-2–Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children

Licciardi, F., Pruccoli, G., Denina, M., Parodi, E., Taglietto, M., Rosati, S., & Montin, D. (2020) · PEDIATRICS · doi:10.1542/peds.2020-1711 · Cited by 224 · see citing works

Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly

YAMAMOTO, K., TAKESHITA, K., KOJIMA, T., TAKAMATSU, J., & SAITO, H. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.11.013 · Cited by 214 · see citing works

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review

Valk, S. J., Piechotta, V., Chai, K. L., Doree, C. J., Monsef, I., Wood, E. M., Lamikanra, A., Kimber, C., McQuilten, Z., So‐Osman, C., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013600 · Cited by 180 · see citing works

Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients

Wang, Z., Du, Z., & Zhu, F. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108214 · Cited by 180 · see citing works

ACEI/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis

Zhang, X., Yu, J., Pan, L., & Jiang, H.-Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104927 · Cited by 177 · see citing works

The association between treatment with heparin and survival in patients with Covid-19

Ayerbe, L., Risco-Risco, C., & Ayis, S. A. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02162-z · Cited by 176 · see citing works

Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.

van Leeuwen, R. T. J., Kol, A., Andreotti, F., Kluft, C., Maseri, A., & Sperti, G. (1994) · Circulation · doi:10.1161/01.cir.90.1.362 · Cited by 173 · see citing works

Coagulopathy of Acute Sepsis

Ammollo, C. T., Semeraro, F., Colucci, M., & Semeraro, N. (2015) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0035-1556730 · Cited by 167 · see citing works

Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count

Bi, X., Su, Z., Yan, H., Du, J., Wang, J., Chen, L., Peng, M., Chen, S., Shen, B., & Li, J. (2020) · Platelets · doi:10.1080/09537104.2020.1760230 · Cited by 166 · see citing works

The Endothelium and Thrombosis

Gross, P. L., & Aird, W. C. (2000) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2000-13202 · Cited by 160 · see citing works

The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19

Perricone, C., Triggianese, P., Bartoloni, E., Cafaro, G., Bonifacio, A. F., Bursi, R., Perricone, R., & Gerli, R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102468 · Cited by 157 · see citing works

Type 3 hypersensitivity in COVID-19 vasculitis

Roncati, L., Ligabue, G., Fabbiani, L., Malagoli, C., Gallo, G., Lusenti, B., Nasillo, V., Manenti, A., & Maiorana, A. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108487 · Cited by 156 · see citing works

Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation

Ikezoe, T. (2015) · Journal of Intensive Care · doi:10.1186/s40560-014-0050-7 · Cited by 150 · see citing works

The Antithrombotic Effect of Angiotensin-(1-7) Involves Mas-Mediated NO Release from Platelets

Fraga-Silva, R. A., Pinheiro, S. V. B., Gonçalves, A. C. D. C., Alenina, N. V., Bäder, M., & Santos, R. A. S. (2008) · Molecular Medicine · doi:10.2119/2007-00073.fraga-silva · Cited by 146 · see citing works

Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin

Foley, J. H., Walton, B. L., Aleman, M. M., O'Byrne, A. M., Lei, V. J., Harrasser, M., Foley, K., Wolberg, A. S., & Conway, E. M. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.011 · Cited by 144 · see citing works

Recruitability and effect of PEEP in SARS-Cov-2-associated acute respiratory distress syndrome

Beloncle, F., Pavlovsky, B., Desprez, C., Fage, N., Olivier, P., Asfar, P., Richard, J., & Mercat, A. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00675-7 · Cited by 138 · see citing works

Analysis on 54 Mortality Cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020

Korean Society of Infectious Diseases and Korea Centers for Disease Control and Prevention (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e132 · Cited by 137 · see citing works

Analysis of complement deposition and viral RNA in placentas of COVID-19 patients

Mulvey, J. J., MAGRO, C. M. J., Ma, L. X., Nuovo, G. J., & Baergen, R. N. (2020) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2020.151530 · Cited by 135 · see citing works

ACE2 Activation Promotes Antithrombotic Activity

Fraga-Silva, R. A., Sorg, B. S., Wankhede, M., deDeugd, C. M., Jun, J. Y., Baker, M. B., Li, Y., Castellano, R. K., Katovich, M. J., Raizada, M. K., et al. (2010) · Molecular Medicine · doi:10.2119/molmed.2009.00160 · Cited by 133 · see citing works

Angiotensin II Increases Plasminogen Activator Inhibitor-1 and Tissue Factor mRNA Expression without Changing that of Tissue Type Plasminogen Activator or Tissue Factor Pathway Inhibitor in Cultured Rat Aortic Endothelial Cells

Nishimura, H., Tsuji, H., Masuda, H., Nakagawa, K., Nakahara, Y., Kitamura, H., Kasahara, T., Sugano, T., Yoshizumi, M., Sawada, S., et al. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656136 · Cited by 130 · see citing works

Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study

Viecca, M., Radovanovic, D., Forleo, G. B., & Santus, P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104950 · Cited by 130 · see citing works

Failure of Anticoagulant Thromboprophylaxis

Lim, W., Meade, M. O., Lauzier, F., Zarychanski, R., Mehta, S., Lamontagne, F., Dodek, P., McIntyre, L., Hall, R., Heels‐Ansdell, D., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000713 · Cited by 129 · see citing works

Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension

Guo, X., Zhu, Y., & Hong, Y. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15572 · Cited by 129 · see citing works

Coexistence of COVID-19 and acute ischemic stroke report of four cases

Tunç, A., Ünlübaş, Y., Alemdar, M., & Akyüz, E. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.05.018 · Cited by 125 · see citing works

Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism

Valle, F. G., Oblitas, C., Jenaro, M. M. F.-M., Muñoz, J. A., del Toro‐Cervera, J., Natale, M. D., & Rodríguez, P. D. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.05.017 · Cited by 124 · see citing works

No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science

Salerno, M., Sessa, F., Piscopo, A., Montana, A., Torrisi, M., Patanè, F. G., Murabito, P., Volti, G. L., & Pomara, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051472 · Cited by 121 · see citing works

Microvascular thrombosis: experimental and clinical implications

Bray, M. A., Sartain, S. E., Gollamudi, J., & Rumbaut, R. E. (2020) · Translational research · doi:10.1016/j.trsl.2020.05.006 · Cited by 119 · see citing works

Pulmonary Embolism and Increased Levels of d -Dimer in Patients with Coronavirus Disease

Griffin, D. O., Jensen, A., Khan, M., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2608.201477 · Cited by 93 · see citing works

First COVID‐19 maternal mortality in the UK associated with thrombotic complications

Ahmed, I., Azhar, A., Eltaweel, N. A., & Tan, B. K. (2020) · British Journal of Haematology · doi:10.1111/bjh.16849 · Cited by 85 · see citing works

Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2−/− mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation

Fang, C., Stavrou, E. X., Schmaier, A. A., Grobe, N., Morris, M., Chen, A., Nieman, M. T., Adams, G. N., Larusch, G. A., Zhou, Y., et al. (2013) · Blood · doi:10.1182/blood-2012-09-459156 · Cited by 84 · see citing works

Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis

Castagné, B., Viprey, M., Martin, J., Schott, A., Cucherat, M., & Soubrier, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220178 · Cited by 84 · see citing works

Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis

Pirola, C. J., & Sookoian, S. C. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.052 · Cited by 84 · see citing works

Colchicine as an anti-inflammatory and cardioprotective agent

Gasparyan, A. Y., Ayvazyan, L., Yessirkepov, M., et al. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1076391 · Cited by 79 · see citing works

Anticardiolipin IgG Autoantibody Level Is an Independent Risk Factor for COVID‐19 Severity

Bertin, D., Brodovitch, A., Beziane, A., Hug, S., Bouamri, A., Mège, J., Heim, X., & Bardin, N. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41409 · Cited by 79 · see citing works

Molecular Pathology in the Lungs of Severe Acute Respiratory Syndrome Patients

Ye, J., Zhang, B., Xu, J., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060469 · Cited by 78 · see citing works

Activation of Coagulation and Fibrinolysis in Acute Respiratory Distress Syndrome: A Prospective Pilot Study

Ozoliņa, A., Šarkele, M., Sabeļņikovs, O., Šķesters, A., Jaunalksne, I., Serova, J., Ievins, T., Bjertnæs, L. J., & Vanags, I. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00064 · Cited by 77 · see citing works

Thrombotic risk in COVID-19: a case series and case–control study

Stoneham, S. M., Milne, K. M., Nuttall, E., Frew, G. H., Sturrock, B. R., Sivaloganathan, H., Ladikou, E. E., Drage, S. M., Phillips, B., Chevassut, T. J. T., et al. (2020) · Clinical Medicine · doi:10.7861/clinmed.2020-0228 · Cited by 75 · see citing works

Pulmonary embolism in a young pregnant woman with COVID-19

Martinelli, I., Ferrazzi, E. M., Ciavarella, A., Erra, R., Iurlaro, E., Ossola, M. W., Lombardi, A., Blasi, F., Mosca, F., & Peyvandi, F. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.022 · Cited by 74 · see citing works

Venous cerebral thrombosis in COVID-19 patient

Garaci, F. G., Giuliano, F. D., Picchi, E., Ros, V. D., & Floris, R. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116871 · Cited by 70 · see citing works

Perspectives of Immune Therapy in Coronavirus Disease 2019

Gasparyan, A. Y., Misra, D. P., Yessirkepov, M., & Zimba, O. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e176 · Cited by 67 · see citing works

The Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas receptor axis: A potential target for treating thrombotic diseases

Fraga‐Silva, R. A., Silva, D. D., Montecucco, F., Mach, F., Stergiopulos, N., da Silva, R., & Santos, R. A. S. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0396 · Cited by 66 · see citing works

Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Research

Gasparyan, A. Y., Ayvazyan, L., Cocco, G., et al. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799504759 · Cited by 64 · see citing works

Colchicine’s effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial

Demidowich, A. P., Levine, J. A., Apps, R., Cheung, F., Chen, J., Fantoni, G., Zhou, H., Shi, R., Subramanian, P., Tsang, J., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0598-3 · Cited by 64 · see citing works

Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cells

Suzuki, Y., Yasui, H., Brzóska, T., et al. (2011) · Blood · doi:10.1182/blood-2011-05-353912 · Cited by 61 · see citing works

Behçet’s Disease as a Model of Venous Thrombosis

Regina, M. L., Gasparyan, A. Y., Orlandini, F., et al. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004010071 · Cited by 61 · see citing works

Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks?

Deftereos, S. G., Γιαννόπουλος, Γ., Vrachatis, D. A., Siasos, G., Giotaki, S. G., CLEMAN, M. W., Dangas, G., & Stefanadis, C. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa033 · Cited by 56 · see citing works

Possible Transfusion-Related Acute Lung Injury Following Convalescent Plasma Transfusion in a Patient With Middle East Respiratory Syndrome

Chun, S., Chung, C. R., Ha, Y. E., et al. (2016) · Annals of Laboratory Medicine · doi:10.3343/alm.2016.36.4.393 · Cited by 55 · see citing works

The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies

Schreiber, K. I., Breen, K. A., Parmar, K., Rand, J. H., Wu, X.-X., & Hunt, B. J. (2017) · Rheumatology · doi:10.1093/rheumatology/kex378 · Cited by 55 · see citing works

FRI0335 THE EFFECT OF TOFACITINIB ON RESIDUAL PAIN IN PATIENTS WITH PSORIATIC ARTHRITIS

Dougados, M., van der Heijde, D. M. F. M., Bingham, C. O., Taylor, P. C., Fallon, L., Woolcott, J. C., Brault, Y., Wang, L., & Kessouri, M. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-eular.949 · Cited by 52 · see citing works

COVID-19 in patients with rheumatological diseases treated with anti-TNF

de Brito, C. A. A., Paiva, J. G. A., Pimentel, F. N., Guimarães, R. S., & Moreira, M. R. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218171 · Cited by 52 · see citing works

Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored

Fan, H., Zhang, L., Huang, B., Zhu, M., Zhou, Y. F., Zhang, H., Tao, X., Cheng, S., Yu, W., Zhu, L., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.024 · Cited by 44 · see citing works

Cardiac troponins predict mortality in patients with COVID-19: A meta-analysis of adjusted risk estimates

Vrsalović, M., & Presečki, A. V. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.022 · Cited by 43 · see citing works

Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?

Zhou, R. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa392 · Cited by 42 · see citing works

Virchow’s triad in “silent” deep vein thrombosis

Lurie, J. M., Png, C. Y. M., Subramaniam, S., et al. (2019) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2019.02.011 · Cited by 38 · see citing works

Transfusion-related acute lung injury (TRALI) after intravenous immunoglobulins: French multicentre study and literature review

Baudel, J.-L., Vigneron, C., Pras-Landre, V., et al. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04832-7 · Cited by 38 · see citing works

Early outcomes with utilization of tissue plasminogen activator in COVID-19–associated respiratory distress: A series of five cases

Christie, D. B., Nemec, H. M., Scott, A. M., et al. (2020) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000002787 · Cited by 37 · see citing works

Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis

Choudhury, R. A., Barrett, C. D., Moore, H. B., et al. (2020) · World Journal of Emergency Surgery · doi:10.1186/s13017-020-00305-4 · Cited by 36 · see citing works

A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?

Maglakelidze, N., Manto, K. M., & Craig, T. (2020) · Pulmonary Therapy · doi:10.1007/s41030-020-00118-5 · Cited by 34 · see citing works

Contrast-enhanced ultrasound (CEUS) of the lung reveals multiple areas of microthrombi in a COVID-19 patient

Tee, A., Wong, A. V.-K., Yusuf, G. T., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06085-4 · Cited by 33 · see citing works

PAI-1 antagonists: the promise and the peril.

Vaughan, D. E. (2011) · PubMed Central · Cited by 32 · see citing works

A specific plasminogen activator inhibitor‐1 antagonist derived from inactivated urokinase

Gong, L., Proulle, V., Fang, C., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12875 · Cited by 29 · see citing works

Pharmacological interventions into the renin–angiotensin system with ACE inhibitors and angiotensin II receptor antagonists: effects beyond blood pressure lowering

Düsing, R. (2016) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944716644130 · Cited by 29 · see citing works

Role of blood cell-associated angiotensin II type 1 receptors in the cerebral microvascular response to ischemic stroke during angiotensin-induced hypertension

Nagai, M., Terao, S., Vital, S. A., et al. (2011) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-3-15 · Cited by 26 · see citing works

Complement and clot

Afshar‐Kharghan, V. (2017) · Blood · doi:10.1182/blood-2017-03-771501 · Cited by 26 · see citing works

Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID‐19 patients

Rodrigues, F. S. M., Tavares, J. G. P., Pires-Oliveira, M., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14902 · Cited by 25 · see citing works

Accelerated Fibrinolysis and Its Propagation on Vascular Endothelial Cells by Secreted and Retained tPA

Urano, T., & Suzuki, Y. (2012) · BioMed Research International · doi:10.1155/2012/208108 · Cited by 24 · see citing works

Primary and Secondary Blood Hyperviscosity Syndromes, and Syndromes Associated with Blood Hyperviscosity

Forconi, S., Pieragalli, D., Guerrini, M., et al. (1987) · Drugs · doi:10.2165/00003495-198700332-00006 · Cited by 24 · see citing works

Inhibition of PAI-1 Activity by Toddalolactone as a Mechanism for Promoting Blood Circulation and Removing Stasis by Chinese Herb Zanthoxylum nitidum var. tomentosum

Yu, B., Zhang, G., Jin, L., Zhang, B., Yan, D., Yang, H. Y., Ye, Z., & Ma, T. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00489 · Cited by 24 · see citing works

Incidental COVID-19 related lung apical findings on stroke CTA during the COVID-19 pandemic

Kihira, S., Schefflein, J., Chung, M., et al. (2020) · Journal of NeuroInterventional Surgery · doi:10.1136/neurintsurg-2020-016188 · Cited by 24 · see citing works

Intravenous immunoglobulin increases plasma viscosity without parallel rise in blood pressure

Bentley, P., Rosso, M., Sadnicka, A., et al. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2011.01287.x · Cited by 23 · see citing works

Optimal Ventilator Strategies in Acute Respiratory Distress Syndrome

Sklar, M. C., Patel, B. K., Beitler, J. R., Piraino, T., & Goligher, E. C. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1683896 · Cited by 21 · see citing works

Ruptured Abdominal Aortic Aneurysm Treated with Endovascular Repair in a Patient with Active COVID-19 Infection during the Pandemic

Shih, M., Swearingen, B. J., & Rhee, R. Y. (2020) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2020.05.001 · Cited by 21 · see citing works

Endovascular Treatment of a Ruptured Pararenal Abdominal Aortic Aneurysm in a Patient With Coronavirus Disease-2019: Suggestions and Case Report

Rinaldi, L. F., Marazzi, G., & Marone, E. M. (2020) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2020.05.011 · Cited by 21 · see citing works

Current Perspectives of Anticoagulation in Patients With COVID-19

Gavioli, E. M., Sikorska, G., Man, A., Rana, J., & Vider, E. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000861 · Cited by 20 · see citing works

A Novel Antithrombotic Mechanism Mediated by the Receptors of the Kallikrein/Kinin and Renin–Angiotensin Systems

Schmaier, A. H. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00061 · Cited by 19 · see citing works

Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease

Piantoni, S., Patroni, A., Toniati, P., et al. (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa217 · Cited by 19 · see citing works

Incidence and risk factors for deep vein thrombosis among pediatric burn patients

Alturki, N., Alkahtani, M., Daghistani, M., et al. (2018) · Burns · doi:10.1016/j.burns.2018.09.032 · Cited by 17 · see citing works

Serologic problems associated with administration of intravenous immune globulin (IVIg)

Branch, D. R. (2019) · Immunohematology · doi:10.21307/immunohematology-2020-006 · Cited by 14 · see citing works

Inhibition of renin-angiotensin axis reduces the risk of thrombus formation in the left atrial appendage in patients with hypertension complicated by atrial fibrillation

Suo, Y., Zhang, Z., Fu, H., Zhang, Y., Yuan, M., Wang, Y., Goudis, C. A., Tse, G., Liu, T., & Li, G. (2018) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320318782623 · Cited by 11 · see citing works

Bradykinin-induced leukocyte– and platelet–endothelium interactions in the cerebral microcirculation

Waldner, M. J., Baethmann, A. J., Uhl, E., & Lehmberg, J. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.010 · Cited by 10 · see citing works

Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19?

Ahmed, S., & Anirvan, P. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05145-w · Cited by 10 · see citing works

Renin-angiotensin system inhibitors in COVID-19

Thomas, G. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc009 · Cited by 10 · see citing works

Immunoglobulin therapy and thrombosis: coincidence or causation?

Drelich, D. A., Bray, P. F., & Herman, J. H. (2012) · Transfusion · doi:10.1111/j.1537-2995.2012.03868.x · Cited by 9 · see citing works

Ramipril and Losartan Exert a Similar Long-Term Effect upon Markers of Heart Failure, Endogenous Fibrinolysis, and Platelet Aggregation in Survivors of ST-Elevation Myocardial Infarction: A Single Centre Randomized Trial

Marinšek, M., & Sinkovič, A. (2016) · BioMed Research International · doi:10.1155/2016/9040457 · Cited by 9 · see citing works

Cautious interpretation of antiphospholipid antibodies in COVID-19

Mehta, S. K., Bhandari, S., & Mehta, S. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.024 · Cited by 9 · see citing works

Behcet's Disease as a Model of Venous Thrombosis~!2009-11-07~!2009-12-07~!2010-02-22~!

Regina, M. L., Gasparyan, A. Y., Orlandini, F., et al. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004020071 · Cited by 9 · see citing works

Plasticity of adult endothelium: how frequent and to what extent?

Pearson, J. D. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv240 · Cited by 7 · see citing works

Ruptured Popliteal Artery Aneurysm Complicated with Acute Respiratory Distress Syndrome Secondary to SARS-CoV-2 Infection

Powezka, K., Khan, T., Narlawar, R. S., et al. (2020) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2020.05.012 · Cited by 6 · see citing works

Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19

D’Agnillo, F., Walters, K.-A., Xiao, Y., Sheng, Z.-M., Scherler, K., Park, J., Gygli, S., Rosas, L. A., Sadtler, K., Kalish, H., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj7790 · Cited by 237 · see citing works

Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a theoretical perspective

Hamidi, S. H., Kadamboor Veethil, S., & Hamidi, S. H. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00255-x · Cited by 50 · see citing works

Endothelial Dysfunction and Hypertension

Lu, X.-Z. (2009) · Advances in Cardiovascular Diseases

von Willebrand Factor, von Willebrand Factor-Cleaving Protease, and Shear Stress

Perutelli, P., & Molinari, A. C. (2007) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152507782109863 · Cited by 10 · see citing works

Comparison of Outcomes after Hospitalization for Deep Venous Thrombosis or Pulmonary Embolism

Murin, S., Romano, P. S., & White, R. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613230 · Cited by 236 · see citing works

[Pulmonary embolism due to deep venous thrombosis of extremities].

Zhang, F., Jin, Y., & Ma, Z. (2000) · PubMed

Deep Venous Thrombosis and Pulmonary Embolism

DeLoughery, T. G. (2014) · Springer eBooks · doi:10.1007/978-3-319-09312-3_15